Zev Gartner's innovative work in 3-D tissue generation has earned him a spot on Popular Science's 'Brilliant 10' list of 2015.

Successful in mice and pigs, researchers hope to test the patch in human clinical trials as early as 2017.

Blocking this protein may prevent the virus' lethal effects, and ultimately may lead to a vaccine.

Federal clearance sets the stage for unlimited clinical use of the tool by Eko Devices, a Skydeck accelerator-nurtured business.

Short sleepers are four times more likely to catch a cold, suggesting a rested immune system works better.

Virus turns host immune cells into suicide machines, using them to spread the virus and cause the progression from infection to disease.

UC Irvine, UC San Diego receive renewed Clinical and Translational Science Awards.

State initiative provides $1.2 million for the Genomics Institute's California Kids Cancer Comparison project.

UCLA and University of Illinois psychologists find a way to change minds.

Use of big data to identify cancer treatments and a DNA sequencing test to diagnose hospital infections are the first projects of UCSF, UC Health initiative.

UCLA study's results are believed to be the first time voluntary leg movements have ever been relearned without surgery.

UC Davis health economists have for the first time projected costs of caring for all people with the disorder.